Prudential Financial
LFCR icon

Prudential Financial’s Lifecore Biomedical LFCR Stock Holding History

Prudential Financial’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,824
Closed -$90.3K – 2481
2025
Q1 		$90.3K Buy
12,824
+89
+0.7% +$553 ﹤0.01% 2140
2024
Q4 		$94.6K Buy
+12,735
New +$81.4K ﹤0.01% 2155
2018
Q3 		– Sell
-10,624
Closed -$158K – 2453
2018
Q2 		$158K Buy
10,624
+20
+0.2% +$278 ﹤0.01% 2364
2018
Q1 		$138K Hold
10,604
– – ﹤0.01% 2281
2017
Q4 		$134K Hold
10,604
– – ﹤0.01% 2284
2017
Q3 		$137K Sell
10,604
-3,110
-23% -$41K ﹤0.01% 2282
2017
Q2 		$204K Sell
13,714
-1,800
-12% -$25.1K ﹤0.01% 2250
2017
Q1 		$187K Hold
15,514
– – ﹤0.01% 2250
2016
Q4 		$215K Sell
15,514
-5,400
-26% -$74.8K ﹤0.01% 2232
2016
Q3 		$281K Sell
20,914
-6,180
-23% -$74.9K ﹤0.01% 2152
2016
Q2 		$292K Buy
27,094
+2,200
+9% +$24.3K ﹤0.01% 2121
2016
Q1 		$262K Buy
+24,894
New +$273K ﹤0.01% 2145

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Prudential Financial's LFCR Position: Q2 2025 in Review

Prudential Financial sold out of Lifecore Biomedical (LFCR) in Q2 2025, closing a stake of 12,824 shares — an estimated $90.3K sold.

Prudential Financial first reported a position in LFCR in Q1 2016 and held it in 12 quarters. The position peaked at $292K in Q2 2016. 86 funds tracked by Wall St. Rank hold LFCR as of Q2 2025.

  • Prudential Financial reported no remaining Lifecore Biomedical position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 12,824 Lifecore Biomedical shares in Q2 2025, an estimated $90.3K.
  • Prudential Financial first reported a position in Lifecore Biomedical in Q1 2016 and held it in 12 quarters.
  • Prudential Financial's Lifecore Biomedical position peaked at $292K in Q2 2016.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.